Also Known As
Mounjaro · Zepbound
Overview
Tirzepatide is a novel dual incretin agonist targeting both GIP and GLP-1 receptors. Shows significant efficacy in metabolic research.
Mechanism of Action
Activates both GIP and GLP-1 receptors, providing complementary effects on insulin, glucagon, appetite, and metabolism.
Quick Reference
Notes
Titrate slowly. Start at lowest dose.
Dosing Protocol
Pharmacokinetics
Administration
Special Instructions
Inject same day each week. Can change injection day if at least 3 days since last dose. Rotate sites.
Warnings
Contraindications
Drug Interactions
Possible Side Effects
Legal & Regulatory
Pregnancy
Molecular Data
No sources available yet.
Related Peptides
No community data available yet. Be the first to add this peptide to your inventory!